EKF Diagnostics Holdings logo

EKF - EKF Diagnostics Holdings Share Price

30.5p -0.5  -1.6%

Last Trade - 06/12/19

Sector
Healthcare
Size
Small Cap
Market Cap £138.5m
Enterprise Value £128.0m
Revenue £43.6m
Position in Universe 890th / 1840
Bullish
Bearish
Unlock EKF Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

EKF Revenue Unlock EKF Revenue

Net Income

EKF Net Income Unlock EKF Revenue

Normalised EPS

EKF Normalised EPS Unlock EKF Revenue

PE Ratio Range

EKF PE Ratio Range Unlock EKF Revenue

Dividend Yield Range

EKF Dividend Yield Range Unlock EKF Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
EKF EPS Forecasts Unlock EKF Revenue
Profile Summary

EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated January 7, 2002
Public Since June 5, 2002
No. of Shareholders: n/a
No. of Employees: 300
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 454,093,227
Free Float (0.0%)
Eligible for
ISAs
SIPPs
EKF Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for EKF
Upcoming Events for EKF
Friday 1st May, 2020 Estimate
EKF Diagnostics Holdings PLC Annual Shareholders Meeting
Similar to EKF
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.